Cecilia Furlong
Stock Analyst at Morgan Stanley
(1.47)
# 3,558
Out of 5,118 analysts
177
Total ratings
45.33%
Success rate
-1.21%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Cecilia Furlong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SGHT Sight Sciences | Maintains: Equal-Weight | $6 → $8 | $8.82 | -9.30% | 18 | Dec 2, 2025 | |
| IRTC iRhythm Technologies | Maintains: Overweight | $195 → $205 | $176.60 | +16.08% | 18 | Dec 2, 2025 | |
| MDT Medtronic | Maintains: Overweight | $107 → $117 | $96.52 | +21.22% | 11 | Nov 19, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Equal-Weight | $115 → $95 | $90.77 | +4.66% | 12 | May 6, 2025 | |
| ISRG Intuitive Surgical | Upgrades: Overweight | $522 → $650 | $577.81 | +12.49% | 13 | Dec 2, 2024 | |
| EMBC Embecta | Maintains: Underweight | $13 → $12 | $12.01 | -0.08% | 12 | Jul 15, 2024 | |
| TMDX TransMedics Group | Maintains: Equal-Weight | $75 → $95 | $124.20 | -23.51% | 12 | Feb 28, 2024 | |
| ALC Alcon | Maintains: Equal-Weight | $78 → $85 | $80.38 | +5.75% | 9 | May 11, 2023 | |
| AORT Artivion | Maintains: Equal-Weight | $14 → $15 | $46.31 | -67.61% | 4 | May 8, 2023 | |
| PODD Insulet | Maintains: Equal-Weight | $325 → $343 | $288.63 | +18.84% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $11 → $14 | $2.22 | +530.63% | 7 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $44 → $48 | $19.38 | +147.68% | 4 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $95 → $102 | $86.85 | +17.44% | 8 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $56 → $58 | $96.06 | -39.62% | 17 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $18 → $20 | $17.18 | +16.41% | 5 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $117 → $131 | $67.57 | +93.87% | 7 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $117 → $133 | $124.84 | +6.54% | 11 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $270 → $220 | $354.22 | -37.89% | 4 | Jul 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $383 → $378 | $122.76 | +207.92% | 2 | Feb 25, 2022 |
Sight Sciences
Dec 2, 2025
Maintains: Equal-Weight
Price Target: $6 → $8
Current: $8.82
Upside: -9.30%
iRhythm Technologies
Dec 2, 2025
Maintains: Overweight
Price Target: $195 → $205
Current: $176.60
Upside: +16.08%
Medtronic
Nov 19, 2025
Maintains: Overweight
Price Target: $107 → $117
Current: $96.52
Upside: +21.22%
Zimmer Biomet Holdings
May 6, 2025
Maintains: Equal-Weight
Price Target: $115 → $95
Current: $90.77
Upside: +4.66%
Intuitive Surgical
Dec 2, 2024
Upgrades: Overweight
Price Target: $522 → $650
Current: $577.81
Upside: +12.49%
Embecta
Jul 15, 2024
Maintains: Underweight
Price Target: $13 → $12
Current: $12.01
Upside: -0.08%
TransMedics Group
Feb 28, 2024
Maintains: Equal-Weight
Price Target: $75 → $95
Current: $124.20
Upside: -23.51%
Alcon
May 11, 2023
Maintains: Equal-Weight
Price Target: $78 → $85
Current: $80.38
Upside: +5.75%
Artivion
May 8, 2023
Maintains: Equal-Weight
Price Target: $14 → $15
Current: $46.31
Upside: -67.61%
Insulet
May 5, 2023
Maintains: Equal-Weight
Price Target: $325 → $343
Current: $288.63
Upside: +18.84%
May 3, 2023
Maintains: Equal-Weight
Price Target: $11 → $14
Current: $2.22
Upside: +530.63%
Apr 28, 2023
Maintains: Equal-Weight
Price Target: $44 → $48
Current: $19.38
Upside: +147.68%
Apr 27, 2023
Maintains: Overweight
Price Target: $95 → $102
Current: $86.85
Upside: +17.44%
Apr 27, 2023
Maintains: Overweight
Price Target: $56 → $58
Current: $96.06
Upside: -39.62%
Feb 23, 2023
Maintains: Equal-Weight
Price Target: $18 → $20
Current: $17.18
Upside: +16.41%
Jan 6, 2023
Maintains: Equal-Weight
Price Target: $117 → $131
Current: $67.57
Upside: +93.87%
Jan 6, 2023
Maintains: Overweight
Price Target: $117 → $133
Current: $124.84
Upside: +6.54%
Jul 15, 2022
Maintains: Equal-Weight
Price Target: $270 → $220
Current: $354.22
Upside: -37.89%
Feb 25, 2022
Maintains: Equal-Weight
Price Target: $383 → $378
Current: $122.76
Upside: +207.92%